EQT Private Equity to acquire Zeus, a leading supplier of custom polymer components to the world's most innovative medical device and industrial companies

EQT私人股本将收购宙斯，宙斯是全球最具创新性的医疗器械和工业公司定制聚合物组件的领先供应商

Transaction highlights EQT's commitment to partnering with leading, purpose-driven companies that deliver inherently critical services to society. Zeus uses its material science expertise to develop advanced components for medical devices used in minimally invasive, life-saving procedures

该交易突显了EQT致力于与领先的、目标驱动的公司合作，为社会提供本质上至关重要的服务。宙斯利用其材料科学专业知识开发用于微创救生程序的医疗设备的先进组件

EQT will support Zeus through investments in additional production capacity, R&D, and operational excellence

EQT将通过在额外生产能力、研发和卓越运营方面的投资来支持宙斯

NEW YORK, Dec. 18, 2023 /PRNewswire/ -- The EQT X fund ('EQT') and Zeus Company, Inc., today jointly announced that they have entered into an agreement for EQT to acquire Zeus Company Inc ('Zeus' or the 'Company') from the Tourville family. Founded in 1966, Zeus is a pioneer in the design, development, and extrusion of fluoropolymer tubing for medical devices and select industrial applications.

纽约，2023年12月18日/PRNewswire/--EQT X基金（“EQT”）和宙斯公司（Zeus Company，Inc.）今天联合宣布，他们已经签订协议，让EQT从图维尔家族收购宙斯公司（Zeus Company Inc）（“Zeus”或“公司”）。宙斯成立于1966年，是医疗器械和部分工业应用氟聚合物管材设计、开发和挤出的先驱。

EQT also announced that John Groetelaars, former CEO of Hillrom and EQT Industrial Advisor, will serve as Zeus' Executive Chairman upon closing of the transaction..

EQT还宣布，Hillrom前首席执行官兼EQT工业顾问约翰·格罗特拉尔斯（JohnGroetelaars）将在交易结束后担任宙斯的执行主席。。

For more than 50 years, Zeus has delivered innovative and mission-critical components that improve the efficacy and performance of highly complex catheters, which are used in life saving, minimally invasive medical procedures, among other applications. The Company is headquartered in Orangeburg, South Carolina, with eight facilities across the United States and one in Letterkenny, Ireland.

50多年来，宙斯一直在提供创新和关键任务组件，以提高高度复杂导管的功效和性能，这些导管用于救生、微创医疗程序等应用。该公司总部位于南卡罗来纳州的奥兰治堡，在美国各地有八家工厂，在爱尔兰的莱特肯尼有一家工厂。

Zeus employs approximately 2,400 people globally and serves over 300 customers in more than 100 countries, including leading medical device manufacturers, contract device manufacturing organizations, academic institutions, and industrial customers across aerospace, semiconductors, and automotive, among other industries.  .

宙斯在全球拥有约2400名员工，为100多个国家的300多家客户提供服务，其中包括领先的医疗器械制造商、合同设备制造组织、学术机构以及航空航天、半导体和汽车等行业的工业客户。。

Zeus' components enable the delivery of minimally invasive interventional procedures, which drive significantly better health outcomes than traditional open surgeries, including faster patient recovery and reduced pain, at lower cost. Zeus has experienced substantial growth as a leading innovator in polymer-based solutions.

宙斯的组件能够提供微创介入手术，这比传统的开放手术带来了更好的健康结果，包括更快的患者康复和减少疼痛，成本更低。作为聚合物解决方案的领先创新者，宙斯取得了长足的发展。

As populations age and chronic conditions become more prevalent, increasing demand for precision, high-performance catheters to support therapeutic areas including structural heart, peripheral and neurovascular interventions, is expected to continue fueling Zeus' growth..

随着人口老龄化和慢性病变得越来越普遍，对精密、高性能导管的需求不断增加，以支持包括结构性心脏、外周和神经血管干预在内的治疗领域，预计将继续推动宙斯的发展。。

EQT will support Zeus with investments in additional capacity, R&D, and operational excellence, to support the rapidly growing medical fields that leverage minimally invasive technologies. These investments will enable the Company to continue its legacy and reputation of partnering with its clients' research and development groups to remain at the forefront of next generation technologies..

EQT将通过在额外产能、研发和卓越运营方面的投资来支持宙斯，以支持利用微创技术的快速发展的医疗领域。这些投资将使该公司能够延续其与客户研发团队合作的传统和声誉，保持在下一代技术的前沿。。

Ethan Waxman, Partner within EQT Private Equity's Advisory Team, said: 'EQT has tracked the medical device component industry closely for several years, and we believe Zeus is uniquely positioned within the end markets it serves due to its unmatched material science and process expertise. We are excited to partner with the Company and invest in its next phase of growth, its employees, and the communities it serves, while maintaining Frank Tourville Sr.'s values and commitment to excellence, which are shared by EQT.'.

EQT私人股本咨询团队的合伙人伊桑·瓦克斯曼（EQT Private Equity）表示：“几年来，EQT一直在密切跟踪医疗器械零部件行业，我们相信宙斯凭借其无与伦比的材料科学和工艺专业知识，在其服务的终端市场中具有独特的地位。我们很高兴与该公司合作，投资于其下一阶段的发展、员工和服务社区，同时保持老弗兰克·图维尔（Frank Tourville Sr.）的价值观和对卓越的承诺，这是EQT所共有的。”。

Steve Peterson, President and CEO of Zeus, added: 'We are excited to join the EQT family. Zeus has gained significant momentum in recent years due to a strategic global expansion plan. This acquisition accelerates that momentum and growth by supporting future expansion, new product innovation, process improvements, technological transformation, and enhanced capabilities.'.

宙斯总裁兼首席执行官史蒂夫·彼得森补充道：“我们很高兴加入EQT家族。由于战略性的全球扩张计划，宙斯近年来取得了巨大的发展势头。此次收购通过支持未来扩张、新产品创新、流程改进、技术改造和增强能力，加速了这种势头和增长。”。

John Groetelaars said: 'I am thrilled to embark on this journey with Zeus and EQT to build upon the Company's impressive legacy and best-in-class, differentiated product portfolio. We are committed to strengthening the partnerships with the customers that Zeus serves and expanding capacity through investments, operational upgrades, and growth from new product innovations.

约翰·格罗特拉尔斯（JohnGroetelaars）说：“我很高兴能与宙斯（Zeus）和EQT一起踏上这段旅程，在公司令人印象深刻的传统和一流的差异化产品组合的基础上再接再厉。我们致力于加强与宙斯服务的客户的合作关系，并通过投资、运营升级和新产品创新的增长来扩大产能。

In the near-term, we intend to expand facilities and add personnel to increase production on behalf of our customers, and we're excited to maintain our status as a key employer in the communities where we operate.'.

在短期内，我们打算扩大设施并增加人员，以代表我们的客户增加产量，我们很高兴能够保持我们在我们经营的社区中作为关键雇主的地位。”。

'As one of the world's leading healthcare investors, EQT invests in innovative companies that are addressing some of the most significant challenges in healthcare today, ranging from life science startups to scaled global businesses,' said Eric Liu, Partner, Head of North American Private Equity and Co-Head of Global Healthcare.

“作为全球领先的医疗保健投资者之一，EQT投资于创新型公司，这些公司正在应对当今医疗保健领域的一些最重大挑战，从生命科学初创公司到规模化的全球企业，”北美私人股本主管兼全球医疗保健联席主管埃里克·刘（EricLiu）说。

'This acquisition represents a highly thematic investment for EQT, given our longtime focus on the medical technology industry and our experience partnering with family-founded businesses. With EQT's deep expertise and broad network of advisors in the healthcare sector, we look forward to continuing our track record of creating differentiated value for all stakeholders.'  .

“鉴于我们长期专注于医疗技术行业以及与家族企业合作的经验，此次收购代表了EQT的高度主题投资。凭借EQT在医疗保健领域的深厚专业知识和广泛的顾问网络，我们期待着继续为所有利益相关者创造差异化价值的记录。”。

The transaction is expected to close in Q1 2024, subject to regulatory approvals and customary closing conditions.

该交易预计将于2024年第1季度完成，但须符合监管部门的批准和惯例成交条件。

Piper Sandler Companies acted as financial advisor to EQT Private Equity and Simpson Thacher & Bartlett LLP provided legal counsel. Goldman Sachs & Co. LLC acted as financial advisor to Zeus and Freshfields Bruckhaus Deringer LLP provided legal counsel. The Private Credit business within Goldman Sachs Asset Management will serve as the Administrative Agent and lead lender in the Senior Secured financing to support the transaction..

Piper Sandler Companys担任EQT Private Equity的财务顾问，Simpson Thacher&Bartlett LLP提供法律顾问。高盛公司（Goldman Sachs&Co.LLC）担任宙斯（Zeus）的财务顾问，Freshfields Bruckhaus Deringer LLP提供法律顾问。高盛资产管理公司（Goldman Sachs Asset Management）旗下的私人信贷业务将担任高级担保融资的管理代理和牵头贷款人，以支持交易。。

With this transaction, EQT X (target fund size of EUR 20.0 billion and a hard cap of EUR 21.5 billion) is expected to be 25-30 percent invested (including closed and/or signed investments, announced public offers, if applicable, and less any expected syndication) based on its target fund size.

通过此次交易，EQT X（目标基金规模为200亿欧元，硬上限为215亿欧元）预计将根据其目标基金规模进行25%至30%的投资（包括已完成和/或签署的投资、已宣布的公开募股（如果适用），并减去任何预期的银团）。

The information contained herein does not constitute an offer to sell, nor a solicitation of an offer to buy, any security, and may not be used or relied upon in connection with any offer or solicitation. Any offer or solicitation in respect of EQT X will be made only through a confidential private placement memorandum and related documents which will be furnished to qualified investors on a confidential basis in accordance with applicable laws and regulations.

此处包含的信息不构成任何证券的出售要约或购买要约的邀约，也不可用于或依赖于任何要约或邀约。关于EQT X的任何要约或招揽只能通过保密的私募备忘录和相关文件进行，这些文件将根据适用的法律法规在保密的基础上提供给合格投资者。

The information contained herein is not for publication or distribution to persons in the United States of America. Any securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the 'Securities Act'), and may not be offered or sold without registration thereunder or pursuant to an available exemption therefrom.

此处包含的信息不用于向美国境内的人士发布或分发。此处提及的任何证券尚未且将不会根据经修订的《1933年美国证券法》（“证券法”）进行登记，未经登记或根据其可用豁免，不得发售或出售。

Any offering of securities to be made in the United States would have to be made by means of an offering document that would be obtainable from the issuer or its agents and would contain detailed information about the issuer of the securities and its management, as well as financial information. The securities may not be offered or sold in the United States absent registration or an exemption from registration..

在美国进行的任何证券发行都必须通过发行人或其代理人提供的发行文件进行，该文件将包含有关证券发行人及其管理层的详细信息以及财务信息。未经登记或登记豁免，不得在美国发售或出售证券。。

About EQTEQT is a purpose-driven global investment organization with EUR 232 billion in total assets under management (EUR 128 billion in fee-generating assets under management), within two business segments – Private Capital and Real Assets. EQT owns portfolio companies and assets in Europe, Asia-Pacific and the Americas and supports them in achieving sustainable growth, operational excellence and market leadership..

关于EQTEQT是一家以目的为导向的全球投资组织，管理的总资产为2320亿欧元（管理的产生费用的资产为1280亿欧元），分为私人资本和房地产两个业务板块。EQT在欧洲、亚太地区和美洲拥有投资组合公司和资产，并支持他们实现可持续增长、卓越运营和市场领导地位。。

More info: www.eqtgroup.com Follow EQT on LinkedIn, X, YouTube and Instagram

More info: www.eqtgroup.com Follow EQT on LinkedIn, X, YouTube and Instagram

About ZeusZeus, headquartered in Orangeburg, South Carolina, is the world's leading polymer extrusion and catheter design manufacturer. With over 55 years of experience in medical, aerospace, energy, automotive, fiber optics, and other leading industries, Zeus' mission is to provide solutions, enable innovation, and enhance lives.

关于宙斯宙斯，总部位于南卡罗莱纳州奥兰治堡，是世界领先的聚合物挤出和导管设计制造商。宙斯在医疗、航空航天、能源、汽车、光纤和其他主导行业拥有超过55年的经验，其使命是提供解决方案，实现创新，改善生活。

The company employs over 2,400 people worldwide with facilities in Aiken, Columbia, Gaston, Orangeburg, and St. Matthews, South Carolina; Branchburg, New Jersey; Chattanooga, Tennessee; San Jose, California; Arden Hills, Minnesota; Guangzhou, China; and Letterkenny, Ireland. For more information, visit www.zeusinc.com..

该公司在全球拥有2400多名员工，其设施位于哥伦比亚省艾肯市、加斯顿市、奥兰治堡市和南卡罗来纳州圣马修斯市；新泽西州布兰奇堡；田纳西州查塔努加；加利福尼亚州圣何塞；明尼苏达州雅顿山；中国广州；和爱尔兰的莱特肯尼。有关更多信息，请访问www.zeusinc.com。。

Logo - https://mma.prnewswire.com/media/2302729/EQT_Logo.jpg

徽标-https://mma.prnewswire.com/media/2302729/eqt_logo.jpg